Somavert and Bursitis - a phase IV clinical study of FDA data


Bursitis is found among people who take Somavert, especially for people who are female, 50-59 old, have been taking the drug for 6 - 12 months.

The phase IV clinical study analyzes which people take Somavert and have Bursitis. It is created by eHealthMe based on reports of 4,489 people who have side effects when taking Somavert from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 29, 2022

4,489 people reported to have side effects when taking Somavert.
Among them, 22 people (0.49%) have Bursitis.

What is Somavert?

Somavert has active ingredients of pegvisomant. eHealthMe is studying from 4,494 Somavert users for its effectiveness, alternative drugs and more.

What is Bursitis?

Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder) is found to be associated with 1,667 drugs and 1,019 conditions by eHealthMe.

Number of Somavert and Bursitis reports submitted per year:

Could Somavert cause Bursitis?

Time on Somavert when people have Bursitis *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 100 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Bursitis when taking Somavert *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Bursitis when taking Somavert *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 9.52 %
  • 50-59: 80.95 %
  • 60+: 9.52 %

Common drugs people take besides Somavert *:

  1. Tecfidera: 18 people, 81.82%
  2. Aubagio: 18 people, 81.82%
  3. Sandostatin: 10 people, 45.45%
  4. Cabergoline: 4 people, 18.18%
  5. Synthroid: 2 people, 9.09%
  6. Metformin: 2 people, 9.09%
  7. Janumet: 1 person, 4.55%
  8. Hydrochlorothiazide: 1 person, 4.55%

Common side effects people have besides Bursitis *:

  1. High Blood Pressure: 20 people, 90.91%
  2. Hypoaesthesia (reduced sense of touch or sensation): 20 people, 90.91%
  3. Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve): 20 people, 90.91%
  4. Infected Dermal Cyst: 18 people, 81.82%
  5. Hair Loss: 18 people, 81.82%
  6. Stress And Anxiety: 18 people, 81.82%
  7. Insulin-Like Growth Factor Decreased: 18 people, 81.82%
  8. Joint Injury: 18 people, 81.82%
  9. Joint Pain: 18 people, 81.82%
  10. Low Density Lipoprotein Increased (cholesterol increased in blood): 18 people, 81.82%

Common conditions people have *:

  1. Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 22 people, 100.00%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 18 people, 81.82%
  3. Diabetes: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Somavert and have Bursitis?

Check whether Bursitis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Bursitis and when was it recovered:

Expand to all the drugs that have ingredients of pegvisomant:

Alternative drugs to, pros and cons of Somavert:

Common Somavert side effects:

Browse all side effects of Somavert:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Bursitis treatments and more:

COVID vaccines that are related to Bursitis:

Common drugs associated with Bursitis:

All the drugs that are associated with Bursitis:

Common conditions associated with Bursitis:

All the conditions that are associated with Bursitis:

How the study uses the data?

The study uses data from the FDA. It is based on pegvisomant (the active ingredients of Somavert) and Somavert (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: